These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 18354252

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does hepcidin affect erythropoiesis in hemodialysis patients?
    Eleftheriadis T, Kartsios C, Liakopoulos V, Antoniadi G, Ditsa M, Papadopoulos C, Anifandis G, Skirta A, Markala D, Stefanidis I.
    Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323
    [Abstract] [Full Text] [Related]

  • 4. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 5. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M, Munaretto G, Spinello M, Rebeschini M, Amici G, Gallieni M, Piccoli A.
    J Nephrol; 2005 Oct; 18(1):72-9. PubMed ID: 15772926
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T, Abe K, Furusu A, Harada T, Shinzato K, Miyazaki M, Kohno S.
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
    Malyszko J, Malyszko JS, Mysliwiec M.
    Kidney Blood Press Res; 2009 Sep; 32(4):235-8. PubMed ID: 19713706
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.
    Rosenlöf K, Kivivuori SM, Grönhagen-Riska C, Teppo AM, Slimes MA.
    Clin Nephrol; 1995 Apr; 43(4):249-55. PubMed ID: 7606879
    [Abstract] [Full Text] [Related]

  • 13. Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
    Costa E, Rocha S, Rocha-Pereira P, Nascimento H, Castro E, Miranda V, Faria Mdo S, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.
    Am J Nephrol; 2008 Apr; 28(6):935-40. PubMed ID: 18587235
    [Abstract] [Full Text] [Related]

  • 14. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
    Yavuz A, Akbaş SH, Tuncer M, Kolağasi O, Cetinkaya R, Gürkan A, Demirbaş A, Gultekin M, Akaydin M, Ersoy F, Yakupoğlu G.
    Transplant Proc; 2004 Apr; 36(1):41-3. PubMed ID: 15013295
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M.
    Beirão I, Almeida S, Swinkels D, Costa PM, Moreira L, Fonseca I, Freitas C, Cabrita A, Porto G.
    Blood Cells Mol Dis; 2008 Apr; 41(2):175-8. PubMed ID: 18544472
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.